Media-OutReach Newswire Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire HKSTP Leads Unprecedented Delegation of 25 Hong Kong Tech Ventures to Tap Fast-Growing Middle East Market at Saudi Arabia's FII8
Media-OutReach Newswire Securities Firms Bullish on Fosun's Growth Path: Boosting Profits, Reducing Leverage
Media-OutReach Newswire ZJLD Group Reported Robust Interim Results of RMB4.1 Billion Revenue for FY2024
Media-OutReach Newswire Fosun’s Core Businesses Grow Significantly, Nomura Reiterates "Overweight" Rating
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 5.